Accessibility navigation

Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs

O'Brien, L. E., Timmins, P., Williams, A. ORCID: and York, P. (2004) Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs. Journal of Pharmaceutical and Biomedical Analysis, 36 (2). pp. 335-340. ISSN 0731-7085

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1016/j.jpba.2004.06.024


The solid-state transformation of carbamazepine from form III to form I was examined by Fourier Transform Raman spectroscopy. Using a novel environmental chamber, the isothermal conversion was monitored in situ at 130◦C, 138◦C, 140◦C and 150◦C. The rate of transformation was monitored by taking the relative intensities of peaks arising from two C H bending modes; this approach minimised errors due to thermal artefacts and variations in power intensities or scattering efficiencies from the samples in which crystal habit changed from a characteristic prism morphology (form III) to whiskers (form I). The solid-state transformation at the different temperatures was fitted to various solid-state kinetic models of which four gave good fits, thus indicating the complexity of the process which is known to occur via a solid–gas–solid mechanism. Arrhenius plots from the kinetic models yielded activation energies from 344 kJ mol−1 to 368 kJ mol−1 for the transformation. The study demonstrates the value of a rapid in situ analysis of drug polymorphic type which can be of value for at-line in-process control.

Item Type:Article
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmaceutics Research Group
ID Code:27363

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation